Molecular Basis of β-Thalassemia Intermedia in Erbil Province of Iraqi Kurdistan

Research output: Contribution to journalArticle

Abstract

β-Thalassemia intermedia (β-TI) is a clinical term describing a range of clinical phenotypes that are intermediate in severity between the carrier state and β-thalassemia major (β-TM). To characterize the molecular basis of β-TI in Erbil Province, Northern Iraq, 83 unrelated patients were investigated. Detection of β-globin gene mutations was carried out by reverse hybridization assay and direct gene sequencing. All patients were screened for the XmnI polymorphism by direct sequencing of HBG2 (Gγ promoter gene). Detection of α-globin gene deletions and triplication was carried out using the reverse hybridization assay. Four main molecular patterns were identified in association with the β-TI phenotype, namely: β++ (38.5%), β+0 (21.6%), β00 (31.3%), and β0/wild type (8.4%). IVS-I-6 (T > C) was the most frequently encountered mutation (55 alleles, 34.6%), followed by IVS-II-1 (G > A) and codon 8 (-AA); furthermore, we report for the first time from Iraq two β+ mutations,-87 (C > G) and 5′ untranslated region (5′UTR) +22 (G > A). The XmnI polymorphism was detected in 47.0% of patients, mainly in association with the β00 genotype. The α-globin gene deletions were encountered in four cases, including one case with (- -FIL) double gene deletion, a report that is the first from our country. The α-globin gene triplication was detected in five of the seven heterozygous β-thalassemia (β-thal) patients. Similar to other Mediterranean countries, inheritance of mild β-globin mutations was the main molecular pattern underlying β-TI in our patients followed by the ameliorating effect of the XmnI polymorphism.

Original languageEnglish
Pages (from-to)178-183
Number of pages6
JournalHemoglobin
Volume39
Issue number3
DOIs
Publication statusPublished - Jun 1 2015

Fingerprint

Globins
beta-Thalassemia
Genes
Gene Deletion
Iraq
Mutation
Polymorphism
Phenotype
Carrier State
Assays
Thalassemia
5' Untranslated Regions
Association reactions
Codon
Alleles
Genotype

Keywords

  • Iraqi Kurdistan
  • XmnI polymorphism
  • β-Thalassemia (β-thal)
  • β-thalassemia intermedia (β-TI) Erbil

ASJC Scopus subject areas

  • Hematology
  • Genetics(clinical)
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Molecular Basis of β-Thalassemia Intermedia in Erbil Province of Iraqi Kurdistan. / Shamoon, Rawand P.; Al-Allawi, Nasir A S; Cappellini, Maria D.; Di Pierro, Elena; Brancaleoni, Valentina; Granata, Francesca.

In: Hemoglobin, Vol. 39, No. 3, 01.06.2015, p. 178-183.

Research output: Contribution to journalArticle

@article{03c398e6117641ae9085ff6e5e43ab61,
title = "Molecular Basis of β-Thalassemia Intermedia in Erbil Province of Iraqi Kurdistan",
abstract = "β-Thalassemia intermedia (β-TI) is a clinical term describing a range of clinical phenotypes that are intermediate in severity between the carrier state and β-thalassemia major (β-TM). To characterize the molecular basis of β-TI in Erbil Province, Northern Iraq, 83 unrelated patients were investigated. Detection of β-globin gene mutations was carried out by reverse hybridization assay and direct gene sequencing. All patients were screened for the XmnI polymorphism by direct sequencing of HBG2 (Gγ promoter gene). Detection of α-globin gene deletions and triplication was carried out using the reverse hybridization assay. Four main molecular patterns were identified in association with the β-TI phenotype, namely: β+/β+ (38.5{\%}), β+/β0 (21.6{\%}), β0/β0 (31.3{\%}), and β0/wild type (8.4{\%}). IVS-I-6 (T > C) was the most frequently encountered mutation (55 alleles, 34.6{\%}), followed by IVS-II-1 (G > A) and codon 8 (-AA); furthermore, we report for the first time from Iraq two β+ mutations,-87 (C > G) and 5′ untranslated region (5′UTR) +22 (G > A). The XmnI polymorphism was detected in 47.0{\%} of patients, mainly in association with the β0/β0 genotype. The α-globin gene deletions were encountered in four cases, including one case with (- -FIL) double gene deletion, a report that is the first from our country. The α-globin gene triplication was detected in five of the seven heterozygous β-thalassemia (β-thal) patients. Similar to other Mediterranean countries, inheritance of mild β-globin mutations was the main molecular pattern underlying β-TI in our patients followed by the ameliorating effect of the XmnI polymorphism.",
keywords = "Iraqi Kurdistan, XmnI polymorphism, β-Thalassemia (β-thal), β-thalassemia intermedia (β-TI) Erbil",
author = "Shamoon, {Rawand P.} and Al-Allawi, {Nasir A S} and Cappellini, {Maria D.} and {Di Pierro}, Elena and Valentina Brancaleoni and Francesca Granata",
year = "2015",
month = "6",
day = "1",
doi = "10.3109/03630269.2015.1032415",
language = "English",
volume = "39",
pages = "178--183",
journal = "Hemoglobin",
issn = "0363-0269",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Molecular Basis of β-Thalassemia Intermedia in Erbil Province of Iraqi Kurdistan

AU - Shamoon, Rawand P.

AU - Al-Allawi, Nasir A S

AU - Cappellini, Maria D.

AU - Di Pierro, Elena

AU - Brancaleoni, Valentina

AU - Granata, Francesca

PY - 2015/6/1

Y1 - 2015/6/1

N2 - β-Thalassemia intermedia (β-TI) is a clinical term describing a range of clinical phenotypes that are intermediate in severity between the carrier state and β-thalassemia major (β-TM). To characterize the molecular basis of β-TI in Erbil Province, Northern Iraq, 83 unrelated patients were investigated. Detection of β-globin gene mutations was carried out by reverse hybridization assay and direct gene sequencing. All patients were screened for the XmnI polymorphism by direct sequencing of HBG2 (Gγ promoter gene). Detection of α-globin gene deletions and triplication was carried out using the reverse hybridization assay. Four main molecular patterns were identified in association with the β-TI phenotype, namely: β+/β+ (38.5%), β+/β0 (21.6%), β0/β0 (31.3%), and β0/wild type (8.4%). IVS-I-6 (T > C) was the most frequently encountered mutation (55 alleles, 34.6%), followed by IVS-II-1 (G > A) and codon 8 (-AA); furthermore, we report for the first time from Iraq two β+ mutations,-87 (C > G) and 5′ untranslated region (5′UTR) +22 (G > A). The XmnI polymorphism was detected in 47.0% of patients, mainly in association with the β0/β0 genotype. The α-globin gene deletions were encountered in four cases, including one case with (- -FIL) double gene deletion, a report that is the first from our country. The α-globin gene triplication was detected in five of the seven heterozygous β-thalassemia (β-thal) patients. Similar to other Mediterranean countries, inheritance of mild β-globin mutations was the main molecular pattern underlying β-TI in our patients followed by the ameliorating effect of the XmnI polymorphism.

AB - β-Thalassemia intermedia (β-TI) is a clinical term describing a range of clinical phenotypes that are intermediate in severity between the carrier state and β-thalassemia major (β-TM). To characterize the molecular basis of β-TI in Erbil Province, Northern Iraq, 83 unrelated patients were investigated. Detection of β-globin gene mutations was carried out by reverse hybridization assay and direct gene sequencing. All patients were screened for the XmnI polymorphism by direct sequencing of HBG2 (Gγ promoter gene). Detection of α-globin gene deletions and triplication was carried out using the reverse hybridization assay. Four main molecular patterns were identified in association with the β-TI phenotype, namely: β+/β+ (38.5%), β+/β0 (21.6%), β0/β0 (31.3%), and β0/wild type (8.4%). IVS-I-6 (T > C) was the most frequently encountered mutation (55 alleles, 34.6%), followed by IVS-II-1 (G > A) and codon 8 (-AA); furthermore, we report for the first time from Iraq two β+ mutations,-87 (C > G) and 5′ untranslated region (5′UTR) +22 (G > A). The XmnI polymorphism was detected in 47.0% of patients, mainly in association with the β0/β0 genotype. The α-globin gene deletions were encountered in four cases, including one case with (- -FIL) double gene deletion, a report that is the first from our country. The α-globin gene triplication was detected in five of the seven heterozygous β-thalassemia (β-thal) patients. Similar to other Mediterranean countries, inheritance of mild β-globin mutations was the main molecular pattern underlying β-TI in our patients followed by the ameliorating effect of the XmnI polymorphism.

KW - Iraqi Kurdistan

KW - XmnI polymorphism

KW - β-Thalassemia (β-thal)

KW - β-thalassemia intermedia (β-TI) Erbil

UR - http://www.scopus.com/inward/record.url?scp=84929449811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929449811&partnerID=8YFLogxK

U2 - 10.3109/03630269.2015.1032415

DO - 10.3109/03630269.2015.1032415

M3 - Article

C2 - 25902180

AN - SCOPUS:84929449811

VL - 39

SP - 178

EP - 183

JO - Hemoglobin

JF - Hemoglobin

SN - 0363-0269

IS - 3

ER -